Iraq vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Iraq
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Iraq rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Iraq
- South-East Asia (WHO region)
How they compare
Iraq currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Iraq's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was South-East Asia (WHO region) ahead.
Iraq ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
Across the 3 decades both report, Iraq averaged higher in 1 and South-East Asia (WHO region) in 2.
Head to head by decade
| Decade | Iraq | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.1% | 0.1% | South-East Asia (WHO region) |
| 2010s | 58.0% | 24.5% | 33.6% | Iraq |
| 2020s | 63.1% | 77.8% | 14.7% | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iraq or South-East Asia (WHO region)?
- Iraq, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iraq and South-East Asia (WHO region)?
- 9.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and South-East Asia (WHO region)?
- 17 years are reported by both, from 2007 to 2024.
- How do Iraq and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Iraq ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.